Close

MM Pharma & Healthcare Packaging reinforces printed aluminum foil production at Piacenza facility; company targets medium-sized pharmaceutical labs with ISO 8 certified cleanroom operations

Apr 8, 2025 Press Release 2 min read

Exclusive Industry Insights

By submitting, you agree to our Privacy Policy

Share this article:

April 8, 2025 (press release) –

MM Pharma & Healthcare Packaging, secondary packaging specialist to the pharmaceutical sector, has reaffirmed its long-term commitment to printed aluminium foil production at its facility in Piacenza, Italy.

With the global printed aluminium foil packaging market projected to reach USD $37 billion by 2032, growing at a CAGR of 4.3% according to Future Market Insights, the company's Italian operation is strategically positioned to meet the specific needs of medium-sized pharmaceutical laboratories requiring high-quality foil solutions.

"For more than three decades, our Piacenza facility has specialized in converting pharma-grade printed aluminium foil to the highest quality standards," said Monica Maschi, Sales Manager & European Key Account at MM Pharma & Healthcare Packaging. "While many larger suppliers focus exclusively on high-volume production, we've developed deep expertise in serving medium-sized pharmaceutical laboratories that require premium quality printed foil in smaller batch sizes. The pharmaceutical industry is increasingly demanding blister packs and push-through closures that provide superior barrier properties against light, moisture and oxygen - areas where aluminium foil excels. Our Italian production capabilities offer significant advantages in responsiveness, customisation and innovation, making our team the ideal partner."

The Piacenza facility operates with an ISO 8 certified cleanroom (Class 100,000), ensuring compliance with stringent pharmaceutical primary packaging standards. This certification guarantees a controlled manufacturing environment with no more than 100,000 particles (0.5 μm) per cubic foot, essential for maintaining the integrity of sensitive pharmaceutical products.

Printed aluminium foil remains a crucial component in pharmaceutical packaging due to its exceptional barrier properties against light, moisture, oxygen and bacteria. Additionally, it provides tamper-evidence capabilities and preserves product efficacy throughout the supply chain.

"Our three decades of experience as foil converters for the pharmaceutical market underlines our long-term commitment to this specialised field" added Maschi. "Through our Italian facility, we offer valuable services that many larger suppliers don't provide, such as variable foil printing and coloured foils. These enhancements not only strengthen packaging security and traceability throughout the supply chain, but also significantly contribute to brand differentiation and recognition. We'll continue to focus on what we do best - providing reliable, high-quality printed aluminium foil solutions for medium-sized orders that combine technical excellence with brand-enhancing features."

To learn more about MM Pharma & HC Packaging’s range of packaging and security solutions, please visit https://www.mm.group/pharma

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Stay Ahead of Changes

Don't Wait. Stay Informed.

The world and your industry are changing too fast. You need to know what's happening, and our Legislation Monitor can help. It's a critical resource for anyone who wants to stay ahead of regulatory and legal challenges. Then, discover the other ways that Industry Intelligence Inc. can help your business.

Cookie Preferences

This website uses cookies to enhance your browsing experience, analyze site performance, and deliver personalized content. We use a minimal cookie to remember your preferences. For detailed information about our cookie usage, please review our Privacy Policy.